Clinical Trial Update: Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States [Phase 2]

View source ↗

Summary

Phase 2 clinical trial to evaluate the efficacy and safety of rosuvastatin for liver cirrhosis in the United States. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Liver Cirrhosis
• Cirrhosis
• Cirrhosis Due to Hepatitis

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Cirrhosis, Cirrhosis, Liver | Phase 2 | Status: RECRUITING